Auto-injectors Market is expected to increase worth USD 5.93 Billion by 2023.
In the year 2018 Global Auto-injectors Market was valued at USD 2.72 billion. By the year 2023, it is predicted to reach USD 5.93 billion with pace of 16.85% CAGR.
(EMAILWIRE.COM, November 01, 2018 ) Market Overview:
In the year 2018 Global Auto-injectors Market was valued at USD 2.72 billion. By the year 2023, it is predicted to reach USD 5.93 billion with pace of 16.85% CAGR.
An auto-injector is a small, pen shaped device, which contains a hypodermic needle used for delivering a fixed dose of drug to patients. These devices are designed for easy and safe administration of the drugs. Auto-injector is mainly used in the treatment of the anaphylaxis, rheumatoid arthritis, multiple sclerosis, and other diseases.
Request Report Sample: https://www.marketdataforecast.com/market-reports/autoinjectors-market-6039/request-sample
Factors affecting market growth:
Increasing prevalence of anaphylaxis incidences, diabetes and cancer diseases across the globe. (+)
Growing adoption of auto-injectors in the global healthcare industries. (+)
Advancement of technologies in medical sector. (+)
Introduction of advanced drug delivery systems. (+)
Increasing investments for R&D activities by private organizations. (+)
Rising healthcare expenditure. (+)
Increasing aging population across the globe. (+)
Lack of awareness towards self-medication among the global population. (-)
Stringent regulatory policies. (-)
High cost associated with auto-injectors devices. (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/autoinjectors-market-6039/customize-report
Market Segmentation
The Global Auto-injectors Market is geographically segmented into
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
North America holds the largest market share in the global auto-injectors market followed by Europe due to increasing prevalence of anaphylaxis, rising healthcare expenditure, advancement of technologies in healthcare services, and increasing of and growth in the pharmaceutical industry. Asia-Pacific is rapidly growing in India and China region due to rising population, increase in chronic diseases, and increasing healthcare expenditure which is expected to contribute high growth rate for auto-injectors market during the forecast period.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/autoinjectors-market-6039/
Key players:
Leading companies for Global Autoinjectors Market are Janssen Global Services LLC, Sanofi, Unilife Corporation, Eli Lilly and Company, Mylan N.V., Pfizer, Inc., Bayer AG, Becton, Dickinson and Company, and Novartis AG, Biogen Idec, Inc.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
In the year 2018 Global Auto-injectors Market was valued at USD 2.72 billion. By the year 2023, it is predicted to reach USD 5.93 billion with pace of 16.85% CAGR.
An auto-injector is a small, pen shaped device, which contains a hypodermic needle used for delivering a fixed dose of drug to patients. These devices are designed for easy and safe administration of the drugs. Auto-injector is mainly used in the treatment of the anaphylaxis, rheumatoid arthritis, multiple sclerosis, and other diseases.
Request Report Sample: https://www.marketdataforecast.com/market-reports/autoinjectors-market-6039/request-sample
Factors affecting market growth:
Increasing prevalence of anaphylaxis incidences, diabetes and cancer diseases across the globe. (+)
Growing adoption of auto-injectors in the global healthcare industries. (+)
Advancement of technologies in medical sector. (+)
Introduction of advanced drug delivery systems. (+)
Increasing investments for R&D activities by private organizations. (+)
Rising healthcare expenditure. (+)
Increasing aging population across the globe. (+)
Lack of awareness towards self-medication among the global population. (-)
Stringent regulatory policies. (-)
High cost associated with auto-injectors devices. (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/autoinjectors-market-6039/customize-report
Market Segmentation
The Global Auto-injectors Market is geographically segmented into
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
North America holds the largest market share in the global auto-injectors market followed by Europe due to increasing prevalence of anaphylaxis, rising healthcare expenditure, advancement of technologies in healthcare services, and increasing of and growth in the pharmaceutical industry. Asia-Pacific is rapidly growing in India and China region due to rising population, increase in chronic diseases, and increasing healthcare expenditure which is expected to contribute high growth rate for auto-injectors market during the forecast period.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/autoinjectors-market-6039/
Key players:
Leading companies for Global Autoinjectors Market are Janssen Global Services LLC, Sanofi, Unilife Corporation, Eli Lilly and Company, Mylan N.V., Pfizer, Inc., Bayer AG, Becton, Dickinson and Company, and Novartis AG, Biogen Idec, Inc.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results